Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints.
about
Background and EpidemiologyInhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.Computed tomography score and pulmonary function in infants with chronic lung disease of infancy.Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotypeUpdate of respiratory tract disease in children with primary ciliary dyskinesia.Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United StatesRespiratory consequences of prematurity: evolution of a diagnosis and development of a comprehensive approach.Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease.Respiratory Function in Healthy Taiwanese Infants: Tidal Breathing Analysis, Passive Mechanics, and Tidal Forced Expiration.Nasal versus oronasal raised volume forced expirations in infants--a real physiologic challenge.Exhaled breath condensate purines correlate with lung function in infants and preschoolersInfant lung function tests as endpoints in the ISIS multicenter clinical trial in cystic fibrosis.Progress in cystic fibrosis and the CF Therapeutics Development NetworkAssociation of lung function, chest radiographs and clinical features in infants with cystic fibrosisYear-in-review 2010: asthma, COPD, cystic fibrosis and airway biology.Update in pediatric lung disease 2010.Update in cystic fibrosis 2010.Lung function distinguishes preschool children with CF from healthy controls in a multi-center setting.An official American Thoracic Society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age.Novel end points for clinical trials in young children with cystic fibrosisDetrimental effects of secondhand smoke exposure on infants with cystic fibrosis.Interpretation of lung function in infants and young children with cystic fibrosis.Novel outcome measures for clinical trials in cystic fibrosisRaised-Volume Forced Expiratory Flow-Volume Curve in Healthy Taiwanese InfantsAn association between pulmonary hypertension and impaired lung function in infants with congenital diaphragmatic hernia.Survey of clinical infant lung function testing practices.Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy.Lung Clearance Index and Structural Lung Disease on Computed Tomography in Early Cystic Fibrosis.Multiple-Breath Washout as a Lung Function Test in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop ReportChanges in Pulmonary Function and Controlled Ventilation-High Resolution CT of Chest After Antibiotic Therapy in Infants and Young Children with Cystic Fibrosis.Chloral hydrate sedation for infant pulmonary function testing.Inhaled hypertonic saline in infants and young children with cystic fibrosis.New reference equations to improve interpretation of infant lung function.Improvement in pulmonary function following antibiotics in infants with cystic fibrosis.Analysis of the associations between lung function and clinical features in preschool children with cystic fibrosis.Lung function over the first 3 years of life in children with congenital diaphragmatic hernia.Early follow-up of lung disease in infants with cystic fibrosis using the raised volume rapid thoracic compression technique and computed tomography during quiet breathing.Changes in multiple breath washout measures after raised volume rapid thoracoabdominal compression maneuvers in infants.
P2860
Q30248742-98B0207D-A923-44EC-B6A7-8855BC3F8C1BQ34275485-D12F632C-BF32-466D-A1D0-1B3A5D039B18Q34997381-F34400EB-2149-41FE-91BF-E1B08D46B989Q35153440-8F689BD4-BC5F-4C04-9B2C-3390F6FE2CA4Q35532206-8C6BE072-2EC6-4C3B-BD24-ED43D2F48692Q35532218-5808D65E-6AED-44E4-B92A-32712A144DDDQ35554148-6EEDCC6B-5BD3-45B2-8190-07F31F795AEEQ35801062-1DAE1268-A77B-4495-85A4-72429E9F215FQ35838880-BA4454F1-E194-4796-9018-2CD733D1A314Q36092143-B2A1B146-388E-4203-B996-1B6198312398Q36209951-D2EAF498-6743-4A51-A763-475D4E4C73FDQ36863409-1673E4D5-077A-47C6-8AD6-CD820931A548Q37209004-A71BBB83-4C83-4E15-85EB-71E2598206E3Q37227977-3E56A23E-0DAA-44DD-BF63-C8842C680B7BQ37845433-0278A5CD-8A1E-41A2-B5FC-44C8B3D64375Q37885064-98CD4B6F-A569-4D08-9729-69457A4B1187Q37892766-781950D5-AFB3-4606-A60A-D3A0B074A1F9Q37955875-CED61262-CD02-40BC-98E4-B4E3635D9EDCQ38100845-3AE4E105-1C2F-4542-A0CD-ABBF7AE25959Q38111791-46E78118-3C42-4363-8625-0566EB7B6EE4Q38194542-300F87ED-0323-498B-AB54-BC9F0366071DQ38221780-2A797197-65C1-48B9-8131-B9021E7CDAA2Q38340406-5A3B6404-0809-4E3A-9AD3-F803011F9E2DQ38663554-84DDF7AA-81AA-4FE0-B7A3-B53935845804Q39232600-BB64AACC-7C93-4077-BC43-1E0B8D27BFC3Q39402580-82E66B09-2BA8-41AF-8034-28318245443CQ39516593-70B0462F-86FA-46F6-9AD5-6BCDB1CD63EEQ40550070-1E9406F7-0623-4ED6-883F-62467163E621Q40834790-1B5E2C2D-C628-470A-A44E-C07F8303480FQ41436908-DDE9CE24-F429-4F7A-97BA-B202CDA153A5Q42838709-2240401F-9BD6-4F80-82B2-8E03A115C448Q43054736-CF261E1E-026A-4584-AB00-F024B49BE795Q43689861-EA287787-CDB8-4AA4-8676-E7ED702C26C6Q43944080-948F7551-18F1-464C-BAE8-14E2A7ED1A07Q44437252-B2696257-92C6-47B5-B837-CD177EEFC73DQ44527301-8EB9E8F4-F8E8-4700-BD23-641D721E57E7Q47786360-BC6F37AD-0E9E-4B42-B3BD-C0168C38B6BDQ51593931-9ACEB0C1-FA8F-4473-BA64-1C0FBCE67215
P2860
Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Multicenter evaluation of infa ...... osis clinical trial endpoints.
@ast
Multicenter evaluation of infa ...... osis clinical trial endpoints.
@en
type
label
Multicenter evaluation of infa ...... osis clinical trial endpoints.
@ast
Multicenter evaluation of infa ...... osis clinical trial endpoints.
@en
prefLabel
Multicenter evaluation of infa ...... osis clinical trial endpoints.
@ast
Multicenter evaluation of infa ...... osis clinical trial endpoints.
@en
P2093
P2860
P1476
Multicenter evaluation of infa ...... osis clinical trial endpoints.
@en
P2093
Andrew A Colin
Carol K Conrad
Gwendolyn S Kerby
James D Acton
Lyndia Brumback
Margaret H Kloster
Margaret Rosenfeld
Meeghan A Hart
Peter J Mogayzel
Peter W Hiatt
P2860
P304
P356
10.1164/RCCM.200908-1236OC
P407
P577
2010-07-09T00:00:00Z